Company: TGE
Filing Date: 2025-07-03
Form Type: F-1/A
Source: 0001213900-25-061211
Chunk: 155

Company: Generation Essentials Group
Filing Date: 2025-07-03
Form: F-1/A
Chunk 155
---
 Risks Relating to Our Securities — Future resales of Ordinary Shares issued
to our shareholders and other significant shareholders may cause the market price of the Class A Ordinary Shares to drop significantly,
even if our business is doing well.” The issuance and sale of additional equity would also result in further dilution to our shareholders.
The incurrence of indebtedness would result in increasing fixed obligations and could result in operating covenants that would restrict
our operations.

We will not receive any proceeds
from any sale of the Registered Securities by the Selling Securityholders. We will receive proceeds of up to an aggregate of approximately
US$186,530,000 from the exercise of the Warrants if all of the Warrants are exercised for cash. However, the exercise price of the Warrants
is US$11.50 per share and the closing price of our Class A Ordinary Shares on the NYSE on June 23, 2025 was US$7.79 per ordinary
share. The likelihood that warrant holders will exercise the Warrants and any cash proceeds that we would receive are dependent upon the
market price of the Class A Ordinary Shares, among other things. If the market price for the Class A Ordinary Shares is less
than US$11.50 per share, we believe warrant holders will be unlikely to exercise their Warrants. There is no assurance that the Warrants
will be “in the money” prior to their expiration or that the warrant holders will exercise their Warrants. Holders of the
Sponsor Warrants have the option to exercise the Sponsor Warrants on a cashless basis in accordance with the Warrant Agreement. To the
extent that any Warrants are exercised on a cashless basis, the amount of cash we would receive from the exercise of the Warrants will
decrease. We will pay the expenses associated with registering the sales by the Selling Securityholders, as described in more details
in the section titled “Use of Proceeds” appearing elsewhere in this prospectus.

We believe that our current
cash and cash equivalents and our anticipated cash flows from operations will be sufficient to meet our anticipated working capital requirements
and capital expenditures for at least the next 12 months. After the Business Combination, we may decide to enhance our liquidity
position or increase our cash reserve for future investments through additional financing. The issuance and sale of additional equity
will result in further dilution to our shareholders. The incurrence of indebtedness will result in increased fixed obligations and could
result in operating covenants that